CVS

CVS Health Corporation NYSE

Healthcare ·Medical - Healthcare Plans ·US · cvshealth.com

$82.09

Mkt Cap $104.3B

52w Low $58.35 88.6% of range 52w High $85.15

50d MA $76.30 200d MA $75.41

P/E (TTM) 58.6x

EV/EBITDA 18.8x

P/B 1.4x

Debt/Equity 1.2x

ROE 2.4%

P/FCF 12.9x

RSI (14) —

ATR (14) —

Beta 0.51

50d MA $76.30

200d MA $75.41

Avg Volume 8.2M

About

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups,… CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 10, 2026	AMC	1.00	1.09	+9.0%	75.62	+0.1%	+1.9%	+3.1%	+3.8%	+3.4%	+2.8%	+0.6%	—
Oct 29, 2025	AMC	1.37	1.60	+16.8%	80.60	-5.6%	-4.9%	-3.0%	-2.7%	-3.1%	-2.5%	-0.3%	—
Jul 31, 2025	AMC	1.46	1.81	+24.0%	62.10	+0.4%	+0.6%	-1.0%	+2.1%	+2.3%	+2.4%	+19.3%	—
May 1, 2025	AMC	1.70	2.25	+32.4%	69.45	+0.4%	-2.9%	-3.4%	-4.6%	-3.8%	-2.3%	-8.4%	—
Feb 12, 2025	AMC	0.91	1.19	+30.2%	63.22	+1.0%	+5.0%	+4.1%	+3.7%	+5.0%	+3.0%	+3.9%	—
Nov 6, 2024	AMC	1.44	1.09	-24.3%	61.61	-0.5%	-7.4%	-9.9%	-9.4%	-12.3%	-11.9%	-10.3%	—
Aug 7, 2024	AMC	1.73	1.83	+5.8%	56.47	-0.3%	+2.4%	+1.1%	-1.2%	-1.2%	-0.8%	+2.3%	—
May 1, 2024	AMC	1.70	1.31	-22.9%	56.31	+0.1%	-2.1%	-0.7%	-0.6%	-1.0%	-2.5%	+5.8%	—
Feb 7, 2024	AMC	2.01	2.12	+5.5%	76.05	-0.2%	-1.3%	+0.4%	+1.6%	+0.7%	+0.5%	-1.3%	—
Nov 1, 2023	AMC	2.13	2.21	+3.8%	68.73	-0.4%	+1.3%	+2.2%	+3.4%	+2.2%	+0.0%	-0.4%	—
Aug 2, 2023	AMC	2.12	2.21	+4.2%	76.41	-0.0%	-2.7%	-4.6%	-3.3%	-3.2%	-2.4%	-14.1%	—
May 3, 2023	AMC	2.07	2.20	+6.3%	70.08	-0.7%	-1.8%	+0.9%	-0.6%	-0.2%	-0.5%	-0.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Baird	Maintains	Outperform → Outperform	—	$77.62	$77.15	-0.6%	-3.4%	-1.1%	-0.4%	-1.3%	-0.3%
Mar 31	Piper Sandler	Maintains	Overweight → Overweight	—	$70.14	$70.40	+0.4%	+2.4%	+3.4%	+4.8%	+4.5%	+11.5%
Mar 12	Bernstein	Upgrade	Market Perform → Outperform	—	$75.72	$76.81	+1.4%	+0.5%	+0.5%	+0.2%	-1.2%	-3.6%
Jan 28	Argus	Maintains	Buy → Buy	—	$72.00	$71.63	-0.5%	+2.8%	+3.4%	+3.5%	+4.8%	+6.7%
Jan 27	BofA Securities	Maintains	Buy → Buy	—	$83.87	$75.39	-10.1%	-14.2%	-11.7%	-11.2%	-11.1%	-10.1%
Jan 6	Bernstein	Maintains	Market Perform → Market Perform	—	$80.42	$80.35	-0.1%	+0.3%	-0.8%	+0.2%	-0.1%	-0.1%
Dec 17	JP Morgan	Maintains	Overweight → Overweight	—	$78.29	$78.50	+0.3%	-0.5%	-0.6%	-0.7%	+0.1%	-0.3%
Dec 12	Bernstein	Maintains	Market Perform → Market Perform	—	$80.83	$81.00	+0.2%	-1.7%	-1.4%	-3.1%	-3.6%	-3.8%
Dec 10	UBS	Maintains	Buy → Buy	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Mizuho	Maintains	Outperform → Outperform	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Piper Sandler	Maintains	Overweight → Overweight	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Baird	Maintains	Outperform → Outperform	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Truist	Maintains	Buy → Buy	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Barclays	Maintains	Overweight → Overweight	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 10	Morgan Stanley	Maintains	Overweight → Overweight	—	$78.24	$78.99	+1.0%	+0.9%	+3.3%	+1.5%	+1.9%	+0.1%
Dec 5	Bernstein	Maintains	Market Perform → Market Perform	—	$76.75	$76.73	-0.0%	-1.5%	-0.3%	+1.9%	+2.9%	+5.3%
Nov 13	Wells Fargo	Maintains	Overweight → Overweight	—	$80.26	$79.23	-1.3%	-1.3%	-3.1%	-2.3%	-2.9%	-4.6%
Nov 3	TD Cowen	Maintains	Buy → Buy	—	$78.15	$78.06	-0.1%	+0.4%	-0.1%	+0.5%	+0.7%	+1.1%
Oct 30	RBC Capital	Maintains	Outperform → Outperform	—	$80.60	$76.08	-5.6%	-4.9%	-3.0%	-2.7%	-3.1%	-2.5%
Oct 30	Evercore ISI	Maintains	Outperform → Outperform	—	$80.60	$76.08	-5.6%	-4.9%	-3.0%	-2.7%	-3.1%	-2.5%
Oct 30	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$80.60	$76.08	-5.6%	-4.9%	-3.0%	-2.7%	-3.1%	-2.5%
Oct 30	Truist	Maintains	Buy → Buy	—	$80.60	$76.08	-5.6%	-4.9%	-3.0%	-2.7%	-3.1%	-2.5%
Oct 24	UBS	Maintains	Buy → Buy	—	$81.07	$81.52	+0.6%	+1.1%	+1.7%	+1.4%	-0.6%	-5.4%
Oct 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$78.44	$78.31	-0.2%	+1.6%	+2.8%	+3.7%	+5.2%	+5.2%
Oct 9	Mizuho	Maintains	Outperform → Outperform	—	$76.93	$77.25	+0.4%	-0.2%	+1.3%	+2.0%	+3.5%	+4.9%
Oct 7	Wells Fargo	Maintains	Overweight → Overweight	—	$76.84	$77.50	+0.9%	+0.4%	+0.1%	-0.1%	+1.4%	+2.1%
Sep 22	Evercore ISI	Maintains	Outperform → Outperform	—	$74.92	$74.32	-0.8%	+0.3%	+2.1%	+1.9%	-0.4%	+1.1%
Sep 5	Bernstein	Maintains	Market Perform → Market Perform	—	$73.69	$73.38	-0.4%	+0.1%	-4.7%	-2.6%	+0.4%	+1.3%
Sep 4	Barclays	Maintains	Overweight → Overweight	—	$73.32	$73.42	+0.1%	+0.5%	+0.6%	-4.2%	-2.1%	+0.9%
Aug 26	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$71.21	$71.25	+0.1%	+0.5%	+1.0%	+1.3%	+2.7%	+4.0%
Aug 18	UBS	Upgrade	Neutral → Buy	—	$68.60	$70.28	+2.4%	+2.3%	+3.5%	+3.2%	+4.1%	+3.9%
Aug 14	Baird	Upgrade	Neutral → Outperform	—	$65.90	$66.61	+1.1%	+1.3%	+4.1%	+6.5%	+7.7%	+7.5%
Aug 1	Morgan Stanley	Maintains	Overweight → Overweight	—	$62.10	$62.32	+0.4%	+0.6%	-1.0%	+2.1%	+2.3%	+2.4%
Aug 1	Barclays	Maintains	Overweight → Overweight	—	$62.10	$62.32	+0.4%	+0.6%	-1.0%	+2.1%	+2.3%	+2.4%
Jul 22	UBS	Maintains	Neutral → Neutral	—	$61.64	$61.09	-0.9%	-0.9%	+0.3%	-4.7%	-1.5%	-3.2%
Jun 30	Jefferies	Maintains	Buy → Buy	—	$68.49	$68.68	+0.3%	+0.7%	+1.6%	-2.8%	-1.5%	-2.6%
Jun 2	Barclays	Maintains	Overweight → Overweight	—	$64.04	$63.51	-0.8%	-0.7%	-0.7%	-0.7%	-1.5%	-0.7%
May 12	Truist	Maintains	Buy → Buy	—	$66.97	$65.66	-2.0%	-3.2%	-9.7%	-10.3%	-9.7%	-6.6%
May 6	Wells Fargo	Maintains	Overweight → Overweight	—	$67.10	$66.92	-0.3%	-1.3%	-0.5%	+1.1%	-0.2%	-3.4%
May 5	RBC Capital	Maintains	Outperform → Outperform	—	$67.46	$68.23	+1.1%	-0.5%	-1.8%	-1.0%	+0.6%	-0.7%
May 2	Barclays	Maintains	Overweight → Overweight	—	$69.45	$69.75	+0.4%	-2.9%	-3.4%	-4.6%	-3.8%	-2.3%
May 2	UBS	Maintains	Neutral → Neutral	—	$69.45	$69.75	+0.4%	-2.9%	-3.4%	-4.6%	-3.8%	-2.3%
Apr 15	Baird	Maintains	Neutral → Neutral	—	$69.20	$69.54	+0.5%	-0.4%	-0.9%	-2.8%	-5.8%	-5.4%
Apr 11	Truist	Maintains	Buy → Buy	—	$68.97	$69.00	+0.0%	+0.8%	+0.3%	-0.1%	-0.6%	-2.4%
Apr 9	Mizuho	Maintains	Outperform → Outperform	—	$67.63	$66.44	-1.8%	+3.8%	+2.0%	+2.8%	+2.3%	+1.9%
Mar 21	Piper Sandler	Maintains	Overweight → Overweight	—	$68.64	$68.46	-0.3%	-2.3%	-1.6%	-3.1%	-2.1%	-1.5%
Feb 18	JP Morgan	Maintains	Overweight → Overweight	—	$65.83	$64.85	-1.5%	-0.4%	+0.9%	-1.1%	-3.6%	-4.3%
Feb 13	Truist	Maintains	Buy → Buy	—	$63.22	$63.86	+1.0%	+5.0%	+4.1%	+3.7%	+5.0%	+3.0%
Feb 13	Barclays	Maintains	Overweight → Overweight	—	$63.22	$63.86	+1.0%	+5.0%	+4.1%	+3.7%	+5.0%	+3.0%
Feb 13	Leerink Partners	Upgrade	Market Perform → Outperform	—	$63.22	$63.86	+1.0%	+5.0%	+4.1%	+3.7%	+5.0%	+3.0%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

CVS appointed Gallina, an independent director and audit committee financial expert, strengthening board oversight and governance credibility, which typically reassures investors about financial integrity and risk management.

Mar 19

8-K

CVS HEALTH CORPORATION -- 8-K Filing

CVS Health's Aetna subsidiary has improved prior authorization processing to approve over 95% of eligible requests within 24 hours, potentially reducing friction in healthcare delivery and strengthening competitive positioning in insurance services.

Feb 10

Data updated apr 25, 2026 4:11am · Source: massive.com